Fluorinated dual antithrombotic compounds based on 1,4-benzoxazine scaffold

Eur J Med Chem. 2012 Apr:50:255-63. doi: 10.1016/j.ejmech.2012.01.059. Epub 2012 Feb 8.

Abstract

Fluorinated 3,4-dihydro-2H-1,4-benzoxazine derivatives possessing both thrombin inhibitory and glycoprotein IIb/IIIa receptor antagonistic activities were prepared as potential dual antithrombotic compounds. Fluorine scan (3-fluorobenzyl, 4-fluorobenzyl, 3,4-difluorobenzyl and 3,5-difluorobenzyl substituted compounds) was performed in order to obtain 6-(carboxymethyl)(3,4-difluorobenzyl)amino compound (9i) as the most potent compound with balanced dual activity (K(i(Thr))=0.33±0.07μM, IC(50(GP IIb/IIIa))=1.1±0.6μM).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzoxazines / chemistry*
  • Halogenation
  • Hemostatics / antagonists & inhibitors*
  • Hemostatics / metabolism
  • Humans
  • Models, Molecular
  • Molecular Structure
  • Platelet Aggregation / drug effects*
  • Platelet Aggregation Inhibitors / chemistry*
  • Platelet Aggregation Inhibitors / pharmacology*
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
  • Platelet Glycoprotein GPIIb-IIIa Complex / metabolism
  • Structure-Activity Relationship
  • Thrombin / antagonists & inhibitors*
  • Thrombin / metabolism

Substances

  • Benzoxazines
  • Hemostatics
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Thrombin